COMBINATION CHEMOIMMUNOTHERAPY - KINETICS OF INVIVO AND INVITRO GENERATION OF NATURAL-KILLER-CELLS AND LYMPHOKINE-ACTIVATED KILLER-CELLS IN THE RAT

被引:0
作者
STEWART, LS
SEWELL, HF
THOMSON, AW
机构
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:416 / 423
页数:8
相关论文
共 29 条
[1]   AUGMENTATION OF DELAYED-TYPE HYPERSENSITIVITY BY DOSES OF CYCLOPHOSPHAMIDE WHICH DO NOT AFFECT ANTIBODY-RESPONSES [J].
ASKENASE, PW ;
HAYDEN, BJ ;
GERSHON, RK .
JOURNAL OF EXPERIMENTAL MEDICINE, 1975, 141 (03) :697-702
[2]  
BALLAS ZK, 1986, J IMMUNOL, V137, P2380
[3]  
DAMLE NK, 1986, J IMMUNOL, V137, P2814
[4]   EFFICACY OF CHEMO-IMMUNOTHERAPY WITH CYCLOPHOSPHAMIDE, INTERLEUKIN-2 AND LYMPHOKINE ACTIVATED KILLER CELLS IN AN INTRAPERITONEAL MURINE TUMOR-MODEL [J].
EGGERMONT, AMM ;
SUGARBAKER, PH .
BRITISH JOURNAL OF CANCER, 1988, 58 (04) :410-414
[5]   LYMPHOKINE-ACTIVATED KILLER CELL PHENOMENON - LYSIS OF NATURAL KILLER-RESISTANT FRESH SOLID TUMOR-CELLS BY INTERLEUKIN 2-ACTIVATED AUTOLOGOUS HUMAN PERIPHERAL-BLOOD LYMPHOCYTES [J].
GRIMM, EA ;
MAZUMDER, A ;
ZHANG, HZ ;
ROSENBERG, SA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (06) :1823-1841
[6]   LYMPHOKINE-ACTIVATED KILLER CELL PHENOMENON .2. PRECURSOR PHENOTYPE IS SEROLOGICALLY DISTINCT FROM PERIPHERAL LYMPHOCYTES-T, MEMORY CYTO-TOXIC THYMUS-DERIVED LYMPHOCYTES, AND NATURAL-KILLER CELLS [J].
GRIMM, EA ;
RAMSEY, KM ;
MAZUMDER, A ;
WILSON, DJ ;
DJEU, JY ;
ROSENBERG, SA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 157 (03) :884-897
[7]   LYT-23+ CYCLOPHOSPHAMIDE-SENSITIVE T-CELLS REGULATE THE ACTIVITY OF AN INTERLEUKIN-2 INHIBITOR INVIVO [J].
HARDT, C ;
ROLLINGHOFF, M ;
PFIZENMAIER, K ;
MOSMANN, H ;
WAGNER, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1981, 154 (02) :262-274
[8]  
HENGST JCD, 1980, CANCER RES, V40, P2135
[9]  
HOSOKAWA M, 1988, CANCER IMMUNOL IMMUN, V26, P250
[10]  
HURME M, 1983, J IMMUNOL, V131, P658